Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
- PMID: 16822902
- PMCID: PMC1895482
- DOI: 10.1182/blood-2006-02-002824
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Abstract
Outcome for children with childhood acute lymphoblastic leukemia (ALL) who relapse is poor. To gain insight into the mechanisms of relapse, we analyzed gene-expression profiles in 35 matched diagnosis/relapse pairs as well as 60 uniformly treated children at relapse using the Affymetrix platform. Matched-pair analyses revealed significant differences in the expression of genes involved in cell-cycle regulation, DNA repair, and apoptosis between diagnostic and early-relapse samples. Many of these pathways have been implicated in tumorigenesis previously and are attractive targets for intervention strategies. In contrast, no common pattern of changes was observed among late-relapse pairs. Early-relapse samples were more likely to be similar to their respective diagnostic sample while we noted greater divergence in gene-expression patterns among late-relapse pairs. Comparison of expression profiles of early- versus late-relapse samples indicated that early-relapse clones were characterized by overexpression of biologic pathways associated with cell-cycle regulation. These results suggest that early-relapse results from the emergence of a related clone, characterized by the up-regulation of genes mediating cell proliferation. In contrast, late relapse appears to be mediated by diverse pathways.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1895482/bin/zh80140698240001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1895482/bin/zh80140698240002.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1895482/bin/zh80140698240003.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1895482/bin/zh80140698240004.gif)
Similar articles
-
Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia.BMC Med Genomics. 2018 Oct 30;11(1):95. doi: 10.1186/s12920-018-0422-2. BMC Med Genomics. 2018. PMID: 30376844 Free PMC article.
-
Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.Arch Immunol Ther Exp (Warsz). 2011 Feb;59(1):61-8. doi: 10.1007/s00005-010-0110-1. Epub 2011 Jan 19. Arch Immunol Ther Exp (Warsz). 2011. PMID: 21246408 Review.
-
Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype.Leukemia. 2010 Mar;24(3):491-9. doi: 10.1038/leu.2009.286. Epub 2010 Jan 14. Leukemia. 2010. PMID: 20072147
-
Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.Clin Cancer Res. 2006 Aug 1;12(15):4553-61. doi: 10.1158/1078-0432.CCR-06-0235. Clin Cancer Res. 2006. PMID: 16899601
-
Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.Haematologica. 2000 Nov;85(11 Suppl):47-53. Haematologica. 2000. PMID: 11268324 Review.
Cited by
-
Gene expression prognostic of early relapse risk in low-risk B-cell acute lymphoblastic leukaemia in children.EJHaem. 2024 Mar 15;5(2):333-345. doi: 10.1002/jha2.872. eCollection 2024 Apr. EJHaem. 2024. PMID: 38633121 Free PMC article.
-
Stem Cell Growth Factor-β as a Predictive Biomarker of Response to Chemotherapy and Prognosis in Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Study.Cancers (Basel). 2024 Jan 11;16(2):320. doi: 10.3390/cancers16020320. Cancers (Basel). 2024. PMID: 38254812 Free PMC article.
-
The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms.Int J Mol Sci. 2023 Dec 21;25(1):119. doi: 10.3390/ijms25010119. Int J Mol Sci. 2023. PMID: 38203290 Free PMC article. Review.
-
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways.Ann Hematol. 2024 May;103(5):1455-1482. doi: 10.1007/s00277-023-05383-3. Epub 2023 Aug 1. Ann Hematol. 2024. PMID: 37526673 Review.
-
Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia.Front Immunol. 2023 Jun 8;14:1191912. doi: 10.3389/fimmu.2023.1191912. eCollection 2023. Front Immunol. 2023. PMID: 37359547 Free PMC article. Review.
References
-
- Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse—the Children's Cancer Group Experience. Cancer. 1998;82: 1387-1395. - PubMed
-
- Gaynon PS. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol. 2005;131: 579-587. - PubMed
-
- Lawson SE, Harrison G, Richards S, et al. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol. 2000;108: 531-543. - PubMed
-
- Roy A, Cargill A, Love S, et al. Outcome after first relapse in childhood acute lymphoblastic leukaemia: lessons from the United Kingdom R2 trial. Br J Haematol. 2005;130: 67-75. - PubMed
-
- Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood. 2004;104: 923-932. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical